NCT00345371View on ClinicalTrials.gov

Topiramate for the Treatment of Methamphetamine Dependence - 1

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

December 31, 2008

Conditions
Methamphetamine
Interventions
DRUG

Topiramate

DRUG

Placebo Oral Tablet

Trial Locations (8)

22911

UVA CARE, Charlottesville

50316

Powell Chemical Dependency Center, Des Moines

64108

University of Missouri - Kansas City, Kansas City

84148

Salt Lake City VA Medical Center, Salt Lake City

90502

Torrance Site, Torrance

92105

South Bay Treatment Center, San Diego

92627

Matrix Institute on Addictions, Costa Mesa

96813

John A. Burns School of Medicine, Honolulu

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00345371 - Topiramate for the Treatment of Methamphetamine Dependence - 1 | Biotech Hunter | Biotech Hunter